# Immunovant, Inc.: Form 8-K, filed Nov 23, 2021

- Company: [Immunovant, Inc.](/companies/imvt.md) (CIK 1764013)
- Form: 8-K
- Filed: 2021-11-23
- Accepted by EDGAR: Nov 23, 2021, 16:27 ET
- Period: 2021-11-17
- Accession: 0001764013-21-000127
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1764013/000176401321000127/imvt-20211117.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1764013/000176401321000127/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1764013/000176401321000127/imvt-20211117.htm

Filed Nov 23, 2021.
Source: SEC EDGAR, the filing index for accession 0001764013-21-000127. Last ingested by Listed: Nov 13, 2026, 16:26 ET. No prices; not investment advice.
